MedTrace Logo

Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast

NCT04597892 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-10-19

No results posted yet for this study

Summary

Point-of-care (POC) creatinine devices allow rapid measurement of creatinine levels and calculation of estimated glomerular filtration rate (eGFR) which give an indication of renal function. The focus of this assessment is to validate POC measurements to assess kidney function before intravascular iodinated contrast administration in patients with severe renal insufficiency (eGFR \< 30 ml/min/1.73m2). It will be evaluated whether discrepancies between POC measurement values and values obtained from standard laboratory assays lie within an acceptable range using Bland-Altman analysis.

Conditions

Interventions

DIAGNOSTIC_TEST

serum creatinine assay

point-of-care and standard laboratory assay of serum creatinine

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2097-05-01
Primary Completion
2099-03-01
Completion
2099-03-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04597892 on ClinicalTrials.gov